Pre-existing evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.
Authors : Bregni G, Trevisi E, Saude Conde R, Vanhooren M, Akin Telli T, Assaf I, Hendlisz A, Di Maio M, Sclafani F Year : 2023 Journal : J Natl Cancer Inst
JCOG0603: Are We Really Sure This Was a Negative Trial?
Authors : Saude Conde R, Bregni G, Saad E, Hendlisz A, Sclafani F Year : 2022 Journal : J Clin Oncol
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.
Authors : Saude Conde R, Rasschaert G, Bregni G, Hendlisz A, Sclafani F Year : 2022 Journal : Curr Opin Oncol
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Authors : Akin Telli T, Bregni G, Vanhooren M, Saude Conde R, Hendlisz A, Sclafani F Year : 2022 Journal : Cancer Treat Rev
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.
Authors : Franzoi MA, Saude Conde R, Ferreira SC, Eiger D, Awada A, de Azambuja E Year : 2021 Journal : Breast